Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124675042 | 12467504 | 2 | F | 20150328 | 20160721 | 20160615 | 20160726 | EXP | JP-ASTELLAS-2016JP009302 | ASTELLAS | 65.00 | YR | M | Y | 52.00000 | KG | 20160726 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124675042 | 12467504 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 0.5 MG, ONCE DAILY | 31.5 | MG | U | 204096 | .5 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | |||
| 124675042 | 12467504 | 2 | SS | NEORAL | CYCLOSPORINE | 1 | Unknown | 0 | 100 | MG | FORMULATION UNKNOWN | QD | |||||||
| 124675042 | 12467504 | 3 | C | MEDROL | METHYLPREDNISOLONE | 1 | Oral | U | 0 | 2 | MG | PER ORAL NOS | QD | ||||||
| 124675042 | 12467504 | 4 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | U | 0 | 1000 | MG | PER ORAL NOS | QD | ||||||
| 124675042 | 12467504 | 5 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | U | 0 | 500 | MG | PER ORAL NOS | QD | ||||||
| 124675042 | 12467504 | 6 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | U | 0 | 1000 | MG | PER ORAL NOS | QD | ||||||
| 124675042 | 12467504 | 7 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | U | 0 | 750 | MG | PER ORAL NOS | QD | ||||||
| 124675042 | 12467504 | 8 | C | EVEROLIMUS | EVEROLIMUS | 1 | Oral | 0.5 MG, ONCE DAILY | U | 0 | .5 | MG | PER ORAL NOS | QD | |||||
| 124675042 | 12467504 | 9 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Unknown | U | 0 | 10 | MG | FORMULATION UNKNOWN | QD | ||||||
| 124675042 | 12467504 | 10 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Unknown | U | 0 | 20 | MG | FORMULATION UNKNOWN | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124675042 | 12467504 | 1 | Prophylaxis against transplant rejection |
| 124675042 | 12467504 | 2 | Prophylaxis against transplant rejection |
| 124675042 | 12467504 | 3 | Prophylaxis against transplant rejection |
| 124675042 | 12467504 | 4 | Prophylaxis against transplant rejection |
| 124675042 | 12467504 | 8 | Prophylaxis against transplant rejection |
| 124675042 | 12467504 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124675042 | 12467504 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124675042 | 12467504 | Transplant rejection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124675042 | 12467504 | 1 | 20150125 | 20160105 | 0 | |
| 124675042 | 12467504 | 2 | 20150124 | 0 | ||
| 124675042 | 12467504 | 6 | 2015 | 2015 | 0 | |
| 124675042 | 12467504 | 7 | 2015 | 0 |